These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17170395)

  • 1. Drug eluting stents.
    Gershlick AH; Richardson G
    BMJ; 2006 Dec; 333(7581):1233-4. PubMed ID: 17170395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very late thrombosis after implantation of sirolimus eluting stent.
    Karvouni E; Korovesis S; Katritsis DG
    Heart; 2005 Jun; 91(6):e45. PubMed ID: 15894746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-eluting coronary stents.
    Ajani AE; Waksman R
    N Engl J Med; 2004 May; 350(20):2099-100; author reply 2099-100. PubMed ID: 15141053
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
    Jang SW; Kim DB; Kwon BJ; Shin D; Her SH; Park CS; Park HJ; Park MW; Cho EJ; Rho TH; Kim JH
    Int J Cardiol; 2010 Apr; 140(1):e8-11. PubMed ID: 19117624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversation with an expert. Plavix: what you need to know.
    O'Gara P
    Harv Heart Lett; 2011 Jan; 21(5):3. PubMed ID: 21322911
    [No Abstract]   [Full Text] [Related]  

  • 9. Late blood clots tarnish drug-coated stents. Uncommon complication raises questions about who really needs a drug-coated stent and how long to continue drug therapy after getting one.
    Harv Heart Lett; 2007 Mar; 17(7):4-5. PubMed ID: 17378075
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.
    Price MJ; Endemann S; Gollapudi RR; Valencia R; Stinis CT; Levisay JP; Ernst A; Sawhney NS; Schatz RA; Teirstein PS
    Eur Heart J; 2008 Apr; 29(8):992-1000. PubMed ID: 18263931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary drug-eluting stents, thrombosis, and antiplatelet therapy: update and recommendations for the practicing pharmacist.
    Dahdal WY; Liu JC
    J Am Pharm Assoc (2003); 2008; 48(3):331-2. PubMed ID: 18623896
    [No Abstract]   [Full Text] [Related]  

  • 12. Stent thrombosis in randomized clinical trials of drug-eluting stents.
    Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
    N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent.
    Sharifkazemi MB; Zamirian M; Aslani A
    Cardiology; 2007; 108(4):273-4. PubMed ID: 17114881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal duration of clopidogrel use after implantation of drug-eluting stents--still in doubt.
    Berger PB
    N Engl J Med; 2010 Apr; 362(15):1441-3. PubMed ID: 20231230
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding and minimizing late thrombosis of drug-eluting stents.
    Rabbat MG; Bavry AA; Bhatt DL; Ellis SG
    Cleve Clin J Med; 2007 Feb; 74(2):129-36. PubMed ID: 17333640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel and stent thrombosis after percutaneous coronary intervention.
    Gladding P; Webster M
    N Z Med J; 2007 Jun; 120(1255):U2554. PubMed ID: 17546102
    [No Abstract]   [Full Text] [Related]  

  • 18. Economics of sirolimus-eluting stents: drug-eluting stents have really arrived.
    Weintraub WS
    Circulation; 2004 Aug; 110(5):472-4. PubMed ID: 15289386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.